Cytoreductive surgery to treat PSD
Doctors at the Wake Forest University School of Medicine have suggested a surgical approach for the treatment of peritoneal surface disease (PSD) that gives positive results. Currently, most patients suffering from colorectal metastases receive chemotherapy as the only treatment. However, the research suggests that combining it with cytoreductive surgery will improve the condition of the patients.
- UPMC Treats 10,000th Patient With Leksell Gamma Knife Radiosurgery System
- Gore Wins European CE Mark Approval for Next Generation Conformable GORE TAG® Thoracic Endoprosthesis
- Boston Scientific’s Advanced Devices to Treat Heart Failure and Sudden Cardiac Death in Availability
- GI Dynamics’ EndoBarrier non-surgical type 2 diabetes therapy receives CE mark approval
